HOME >> BIOLOGY >> NEWS
Biomedical scientist testing nanoparticles as early cancer detection agent

various patients. Even when cells appear to be similar under the microscope, their genes and proteins may be decidedly different, which explains why cancer patients with apparently similar cancers sometimes respond differently to the same treatment.

Nie and his colleagues are working on methods to deliver nanoparticles into specific kinds of tissues and cells -- a process that would make cancer therapy more selective. Using near-infrared imaging technology, they are monitoring the migration of the particles within cells.

Nie is also working with tissue engineers at Georgia Tech and Emory to study the use of nanoparticles to construct new materials that could be used as improved implants for damaged tissue, such as bone, cartilage, or skin. Bio-nanomaterials provide new opportunities in cell and tissue engineering, such as cell growth/differentiation, tissue scaffolding, and controlled release of multiple growth factors.


'"/>

Contact: Larry Bowie
larry.bowie@icpa.gatech.edu
404-894-6016
Georgia Institute of Technology Research News
23-Oct-2002


Page: 1 2 3 4

Related biology news :

1. Pittsburgh NMR Center for Biomedical Research at Carnegie Mellon
2. Biomedical engineer constructs illuminating nanoparticles for medical imaging and gene detection
3. Yale researcher receives $1.3 million NIH grant to build Center of Excellence in Biomedical Computing
4. Rutgers to start up National Program of Excellence in Biomedical Computing
5. University of Pittsburgh, Carnegie Mellon University establish Biomedical Security Institute to address bioterrorism, public health threats
6. Biomedical scientists from Russia to Rio to explore biologys frontiers at HHMI in June
7. Biomedical switch regulates how cells stick together and communicates
8. Biomedical engineers working to help kids with special needs
9. Cutting The Time And Cost Of Developing New Cures: Lord Sainsbury Launches Worlds First Biomedical Accelerator Mass Spectrometer In York
10. Nations Leading Biomedical Researchers Present Breakthroughs in Liver Disease
11. University Of Kentucky Biomedical Engineer Awarded Grant To Improve Joint Replacements And Dental Implants

Post Your Comments:
(Date:11/18/2014)... 17, 2014 The Parenteral Drug Association (PDA) today ... will speak and at least seven more will participate in ... Omni Shoreham Hotel in Washington D.C. , ... have significant support from the regulatory agencies in ... in our effort to help advance the use of ...
(Date:11/12/2014)... , Nov. 12, 2014 Crossmatch™, a leading ... its U.are.U ® fingerprint readers have been deployed ... Central Mexico . The bakery chain ... eliminate payroll issues caused by employees clocking in for ... U.are.U fingerprint readers, Montparnasse relied on paper timecards and ...
(Date:11/7/2014)... Dr. Debra Auguste, associate professor, biomedical engineering, in ... College of New York, have identified a molecule ... of the most aggressive forms of breast cancer. ... high mortality rate owing to aggressive proliferation and ... However, Professor Auguste,s team, discovered the overexpression of ...
Breaking Biology News(10 mins):FDA's Janet Woodcock, EMA's Emer Cooke Headline PDA Quality Metrics Conference 2Montparnasse Pasteleria Achieves Time and Attendance Transparency with Crossmatch U.are.U Fingerprint Readers 2
(Date:11/18/2014)... Array Architects is proud of a 30-year ... nation's hospitals and health systems. It is a niche ... careers to the advancement of both the healthcare and ... field, Laura Silvoy has been chosen to share her ... Conference. , Laura will present her Process Simulation ...
(Date:11/18/2014)... MENLO PARK, Calif. , Nov. 18, 2014 ... leading biotechnology company in the emerging field of ... clinical program, AST-OPC1 (oligodendrocyte progenitor cells) for complete ... as one of ten "Top Advanced Therapies Projects ... "We are delighted to receive this significant industry ...
(Date:11/18/2014)... , Nov. 18, 2014  Novira Therapeutics, Inc., a ... treatment of chronic hepatitis B virus (HBV) infection, today ... appointed to its Scientific Advisory Board (SAB).  ... SAB," said Christian S. Schade , Chief Executive ... development experience which will be invaluable to Novira as ...
(Date:11/17/2014)... , Nov. 17, 2014 Soligenix, ... late-stage biopharmaceutical company developing products that address unmet ... and biodefense, announced today the formation of a ... guidance to the Company as it advances the ... for the treatment of cutaneous T-cell lymphoma (CTCL), ...
Breaking Biology Technology:Array Healthcare Simulation Expert Slated to Speak at Winter Simulation Conference 2Asterias Biotherapeutics Named as a "Top Advanced Therapies Projects to Watch" and Will Present at the Therapeutic Area Partnerships Conference 2Asterias Biotherapeutics Named as a "Top Advanced Therapies Projects to Watch" and Will Present at the Therapeutic Area Partnerships Conference 3Novira Therapeutics Announces Appointment of Brian F. Daniels, M.D., to its Scientific Advisory Board 2Novira Therapeutics Announces Appointment of Brian F. Daniels, M.D., to its Scientific Advisory Board 3Soligenix Announces Formation of Cutaneous T-Cell Lymphoma Medical Advisory Board 2Soligenix Announces Formation of Cutaneous T-Cell Lymphoma Medical Advisory Board 3Soligenix Announces Formation of Cutaneous T-Cell Lymphoma Medical Advisory Board 4Soligenix Announces Formation of Cutaneous T-Cell Lymphoma Medical Advisory Board 5Soligenix Announces Formation of Cutaneous T-Cell Lymphoma Medical Advisory Board 6
Cached News: